SFM
Sphera Funds Management’s GSK GSK Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $4.68M | Sell |
122,000
-8,000
| -6% | -$307K | 1.1% | 27 |
|
2025
Q1 | $5.04M | Hold |
130,000
| – | – | 1.16% | 26 |
|
2024
Q4 | $4.4M | Buy |
130,000
+30,000
| +30% | +$1.01M | 0.79% | 45 |
|
2024
Q3 | $4.09M | Hold |
100,000
| – | – | 0.65% | 48 |
|
2024
Q2 | $3.85M | Hold |
100,000
| – | – | 0.53% | 55 |
|
2024
Q1 | $4.29M | Hold |
100,000
| – | – | 0.6% | 51 |
|
2023
Q4 | $3.71M | Hold |
100,000
| – | – | 0.6% | 56 |
|
2023
Q3 | $3.63M | Hold |
100,000
| – | – | 0.66% | 48 |
|
2023
Q2 | $3.56M | Buy |
+100,000
| New | +$3.56M | 0.56% | 52 |
|
2019
Q3 | – | Sell |
-500,000
| Closed | -$20M | – | 85 |
|
2019
Q2 | $20M | Buy |
500,000
+70,000
| +16% | +$2.8M | 2.74% | 9 |
|
2019
Q1 | $18M | Buy |
430,000
+120,000
| +39% | +$5.01M | 1.64% | 11 |
|
2018
Q4 | $11.8M | Sell |
310,000
-555,000
| -64% | -$21.2M | 1.34% | 19 |
|
2018
Q3 | $34.7M | Buy |
865,000
+100,000
| +13% | +$4.02M | 3.99% | 4 |
|
2018
Q2 | $30.8M | Buy |
765,000
+265,000
| +53% | +$10.7M | 4.25% | 3 |
|
2018
Q1 | $19.5M | Buy |
500,000
+50,000
| +11% | +$1.95M | 2.97% | 7 |
|
2017
Q4 | $16M | Hold |
450,000
| – | – | 1.87% | 6 |
|
2017
Q3 | $18.3M | Hold |
450,000
| – | – | 2.61% | 5 |
|
2017
Q2 | $19.4M | Buy |
+450,000
| New | +$19.4M | 3.3% | 4 |
|
2016
Q3 | – | Sell |
-398,287
| Closed | -$6.39M | – | 111 |
|
2016
Q2 | $6.39M | Buy |
+398,287
| New | +$6.39M | 1.66% | 12 |
|
2015
Q1 | – | Sell |
-98,200
| Closed | -$4.2M | – | 143 |
|
2014
Q4 | $4.2M | Buy |
98,200
+1,100
| +1% | +$47K | 0.72% | 39 |
|
2014
Q3 | $4.46M | Sell |
97,100
-202,900
| -68% | -$9.33M | 0.55% | 38 |
|
2014
Q2 | $16M | Sell |
300,000
-350,000
| -54% | -$18.7M | 3.95% | 6 |
|
2014
Q1 | $34.7M | Buy |
650,000
+100,000
| +18% | +$5.34M | 7.93% | 2 |
|
2013
Q4 | $29.4M | Buy |
+550,000
| New | +$29.4M | 8.18% | 1 |
|